Efficacy of Adding Oral Simvastatin to Topical Therapy for Treatment of Psoriasis: The Vietnamese Experience

BACKGROUND: Psoriasis, the prevalence of which ranges from 2% to 3% of the general population, has been recently recognised as not only a chronic inflammatory skin disorder but also an immunometabolic systemic disease. Dyslipidemia is one of the most important comorbidities of psoriasis. Statins, fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Trong, Hao Nguyen, Tat, Thang Nguyen, Anh, Tu Tran Nguyen, Uyen, Nhi Pham, Van, Thuong Nguyen, Hau, Khang Tran, Gandolfi, Marco, Satolli, Francesca, Feliciani, Claudio, Tirant, Michael, Vojvodic, Aleksandra, Lotti, Torello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364708/
https://www.ncbi.nlm.nih.gov/pubmed/30745969
http://dx.doi.org/10.3889/oamjms.2019.060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364708/
https://www.ncbi.nlm.nih.gov/pubmed/30745969
http://dx.doi.org/10.3889/oamjms.2019.060

Ejemplares similares